Data Insights Platform for Life Sciences

Ergo allows users to extract insights to make meaningful discoveries from the vast body of scientific evidence available. Explore what is known about a biomedical entity such as a gene, disease, or drug, to answer questions and discover new connections with ease. Users’ proprietary data can be easily integrated directly into the knowledge network, or processed through the Ergo Engine as a custom unstructured or structured data source.

  • Accelerate identification and prioritization of novel drug targets. Ergo empowers scientists to quickly identify and prioritize novel drug targets using available information in one location.
  • Better prioritize your lead compounds and de-risk subsequent investments. Compare compound performance across early stage discovery to identify leads, suggest MOA, and discover other therapeutics targeting similar diseases, pathways, and targets.
  • Analyze your proprietary assays and data within the larger biological context. ERGO integrates your proprietary data within the biological knowledge network allowing you to use this  larger biological context to assess significance, enrichments, and better interpret results.

Read more about how we’ve implemented our ERGO platform to accelerate research in COVID-19, oncology, and agricultural biotech.

Some of our thoughts on using NLP to advance discovery